Evolent Health Stock Investor Sentiment

EVH Stock  USD 12.21  0.96  8.53%   
Under 69 percent of all Evolent Health's traders are curious in acquiring. The analysis of the overall investor sentiment regarding Evolent Health suggests that a large number of traders are confidant. Evolent Health's investing sentiment shows overall attitude of investors towards Evolent Health.
  

Evolent Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Evolent Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at seekingalpha.com         
Evolent Health Non-GAAP EPS of 0.30 beats by 0.05, revenue of 647.1M beats by 10.69M
seekingalpha News
over three months ago at finance.yahoo.com         
Evolent Health Surpasses Q2 Earnings and Revenue Estimates
Yahoo News
over three months ago at finance.yahoo.com         
Evolent Announces Second Quarter 2024 Results
Yahoo News
over three months ago at investing.com         
Evolent Health Inc earnings beat by 0.05, revenue topped estimates
Investing News at Macroaxis
over three months ago at seekingalpha.com         
Evolent Health Q2 2024 Earnings Preview
seekingalpha News
over three months ago at investorplace.com         
3 Top Tech Stocks Ready for Robust Gains
sbwire news
over three months ago at thelincolnianonline.com         
Stephens Reiterates Overweight Rating for Evolent Health
news
over three months ago at www.macroaxis.com         
Disposition of 2567 shares by Aammaad Shams of Evolent Health at 22.44 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Evolent Health Given Overweight Rating at Stephens - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Evolent Health, Inc. Sees Large Growth in Short Interest - MarketBeat
Google News at Macroaxis
over three months ago at simplywall.st         
Potential Upside For Evolent Health, Inc. Not Without Risk
Simply Wall St News at Macroaxis
over three months ago at news.google.com         
Evolent Health, Inc. Shares Sold by Russell Investments Group Ltd. - Defense World
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare d...
Yahoo News
over three months ago at news.google.com         
Objective longshort Report - Stock Traders Daily
Google News at Macroaxis
over three months ago at news.google.com         
Evolent Health, Inc. Shares Sold by Swiss National Bank - American Banking and Market News
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Evolent Health that are available to investors today. That information is available publicly through Evolent media outlets and privately through word of mouth or via Evolent internal channels. However, regardless of the origin, that massive amount of Evolent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Evolent Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Evolent Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Evolent Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Evolent Health alpha.

Evolent Health Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 2569 shares by Aammaad Shams of Evolent Health at 34.41 subject to Rule 16b-3
09/06/2024
2
Evolent Health Inc Shares Up 3.72 percent on Oct 30
10/30/2024
3
Evolent Announces Third Quarter 2024 Results
11/07/2024
4
Q3 2024 Evolent Health Inc Earnings Call Transcript
11/08/2024
5
Evolent Health Inc Shares Down 4.96 percent on Nov 12
11/12/2024
6
FMR LLC Adjusts Stake in Evolent Health Inc
11/13/2024
7
Granahan Investment Management Reduces Stake in Indie Semiconductor
11/15/2024
8
Evolent Health, Inc. This Small-Cap Stock Is Ready To Explode
11/19/2024

Complementary Tools for Evolent Stock analysis

When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Managers
Screen money managers from public funds and ETFs managed around the world